GeminIQ Website Logo

Viewing MDLN free

Subscribe for full history, 50+ metrics, screener, watchlist...

Medline Inc.

MDLN

Companies in Surgical & Medical Instruments & Apparatus

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
2,2361,939
Accounts Receivable Net Current
3,6743,533
Inventory Net
4,8074,769
Other Assets Current
463438
Assets Current
11,18010,679
Property Plant And Equipment Net
4,7584,778
Other Assets Noncurrent
Goodwill
8,0768,079
Intangible Assets Net Excluding Goodwill
13,71713,893
Deferred Income Tax Assets Net
837583
Other Assets Miscellaneous Noncurrent
446472
Other Assets Noncurrent
23,07623,027
Assets
39,01438,484
Liabilities And Stockhold…
Liabilities Current
Debt Current
7777
Accounts Payable Current
932961
Accrued Liabilities Current
1,5271,452
Liabilities Current
2,5362,490
Liabilities Noncurrent
Long Term Debt Noncurrent
12,49512,484
Other Liabilities Noncurrent
625682
Liabilities Noncurrent
17,12916,708
Liabilities
19,66519,198
Temporary Equity Carrying Amount Attributable To P…
-367
Stockholders Equity Inclu…
Partners Capital
Preferred Stock Value
00
Additional Paid In Capital
11,13210,717
Retained Earnings Accumulated Deficit
122-7
Accumulated Other Comprehensive Income Loss Net Of…
1827
Stockholders Equity
11,27210,737
Partners Capital
-16,872
Minority Interest
8,0778,549
Liabilities And Stockholders Equity
39,01438,484
Common Class A
8460
Common Class B
4680
Allowance For Doubtful Accounts Receivable Current
148152
Preferred Stock Par Or Stated Value Per Share
00
Preferred Stock Shares Authorized
5,0005,000
Preferred Stock Shares Issued
00
Preferred Stock Shares Outstanding
00

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-12.97%-7.47%----
2025----11.31%-1.12%-24.89%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
4.41
4.29
Quick Ratio
2.51
2.37
Working Capital
8.64B
8.19B
Leverage & Debt
Debt to Equity
1.02
1.00
Debt Ratio
0.50
0.50
Valuation Metrics
P/B TTM
1.88
1.76
Market Cap
36.45B
34.02B
Enterprise Value
46.78B
44.64B
Calculated Values
Net Debt
10.33B
10.62B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-16Sale
Owner: Golwas, Douglas P
Title: Chief Commercial Officer
Shares: 100,000
Price/Share: $36.83
Value: $3,683,000.00
Shares Owned: 23,899
Relationship: Officer,TenPercentOwner
Ownership: Direct
2026-06-05Purchase
Owner: Corcoran, Jessi L
Title: Principal Accounting Officer
Shares: 5,000
Price/Share: $34.15
Value: $170,750.00
Shares Owned: 5,000
Relationship: Officer
Ownership: Direct
2026-05-28Sale
Owner: Mend, Partners Ii, L.P., …
Title: -
Shares: 31,868,237
Price/Share: $36.54
Value: $1,164,465,379.98
Shares Owned: 228,840
Relationship: TenPercentOwner
Ownership: Indirect
2026-05-28Sale
Owner: Bcp, 8 Holdings Mozart Ma…
Title: -
Shares: 33,317,824
Price/Share: $36.54
Value: $1,217,433,288.96
Shares Owned: 1,539
Relationship: TenPercentOwner
Ownership: Indirect
2026-05-28Sale
Owner: Bx, Mozart Ml-2 Holdco Gp…
Title: -
Shares: 33,317,824
Price/Share: $36.54
Value: $1,217,433,288.96
Shares Owned: 1,539
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
76.21%
Inst. Shares: 624,239,555
Shares Outstanding: 819,082,538
2025-12-31
68.49%
Inst. Shares: 554,784,108
Shares Outstanding: 810,000,000

Medline Inc. (MDLN) — SEC Financial Statements & Analysis

Medline Inc. (MDLN) is a surgical & medical instruments & apparatus company, incorporated in DE. Medline Inc. trades on MDLN: Nasdaq as: MDLN. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Medline Inc. reported a Debt-to-Equity ratio of 1.02x, a Price-to-Book (P/B) ratio of 1.88 (TTM), at a market cap of $36.45B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
1.02x
P/B TTM
1.88
Market Cap
$36.45B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Medline Inc. in?

Medline Inc. (MDLN) operates in the Surgical & Medical Instruments & Apparatus industry.

What is MDLN's market cap?

Medline Inc. (MDLN) has a market capitalization of $36.45B as of 2026-03-31.

What exchange does MDLN trade on?

Medline Inc. (MDLN) trades on the MDLN: Nasdaq.

Where is Medline Inc. incorporated?

Medline Inc. is incorporated in DE.

Research Faster.
Invest Smarter.

Medline Inc. (MDLN) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.